In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.
Whole-cell and soluble extracts of Leishmania promastigotes have both been used as skin test antigens and have also been tested as vaccine candidates. However, the differences in antigenicity between soluble and particulate Leishmania fractions are not known. We evaluated in vitro responses of PBMC from 30 American tegumentary leishmaniasis (ATL) patients and seven noninfected donors to different antigen preparations from Leishmania promastigotes, namely Leishmania amazonensis and L. braziliensis whole-cell extracts, as well as soluble and particulate fractions of L. amazonensis. All Leishmania antigen preparations stimulated significantly higher proliferation and interferon (IFN)-gamma production (but not interleukin (IL)-10 production) in PBMC from the leishmaniasis patients than in cells from the control subjects. The L. braziliensis whole-cell extract stimulated significantly higher cell proliferation and IFN-gamma production than the L. amazonensis whole-cell extract in the group of patients but not in the control group. This result can be explained by the fact that the patients were infected with L. braziliensis. Again in the group of patients, the PBMC proliferative responses as well as the levels of IFN-gamma and IL-10 stimulated by L. amazonensis whole-cell extract were significantly greater than those elicited by the L. amazonensis soluble fraction but were not significantly different from those elicited by the L. amazonensis particulate fraction. We found a higher antigenicity of the particulate fraction as compared to the soluble fraction, what suggests that the antigens present in the particulate fraction account for most of the antigenicity of whole-cell Leishmania promastigote antigen extracts.
Telino
E
E
Department of Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
De Luca
P M
PM
Matos
D C S
DC
Azeredo-Coutinho
R B
RB
Meirelles
M N
MN
Conceição-Silva
F
F
Schubach
A
A
Mendonça
S C F
SC
D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology*; D002455:Cell Division / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D016753:Interleukin-10 / Q000276:immunology; D007891:Leishmania / Q000276:immunology* / Q000648:ultrastructure; D007892:Leishmania braziliensis / Q000276:immunology / Q000648:ultrastructure; D016773:Leishmaniasis, Cutaneous / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008854:Microscopy, Electron; D012995:Solubility
D000953:Antigens, Protozoan; D016753:Interleukin-10; D007371:Interferon-gamma